MAIBYS MOLINA: Open Payments
NPI 1033526140 · HIALEAH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,065 in 91 payments from 18 companies in 2025. Trend: 2023 $238 · 2024 $1,098 · 2025 $2,065
Food & beverage: $2,065
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 10 | $411 |
| ABBVIE INC. | 16 | $273 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $173 |
| Ipsen Biopharmaceuticals, Inc | 6 | $150 |
| QOL Medical, LLC | 7 | $146 |
| GENZYME CORPORATION | 6 | $143 |
| Lilly USA, LLC | 5 | $107 |
| Intercept Pharmaceuticals, Inc. | 4 | $101 |
| Janssen Biotech, Inc. | 4 | $100 |
| Ardelyx, Inc. | 5 | $89 |
Products named: REZDIFFRA, IQIRVO, Sucraid, DUPIXENT, LINZESS, EOHILIA, OMVOH, OCALIVA.
Industry payments across FL — which companies pay providers there.
